Dive Into Dollar Tr...
Health Care: Health Services
Edap TMS SA (EDAP: NASDAQ)
$4.18 0.41 | 10.88%
05/17/13 - 03:59 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -9.89M | -1.22M | -16.91M | -11.13M |
| Operating Gains/Losses | 383.53K | 460.11K | 103.74K | 170.50K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 3.32M | -222.93K | 194.17K | -1.29M |
| (Increase) Decrease in Inventories | -657.28K | -565.10K | -472.14K | -457.05K |
| (Increase) Decrease In Other Current Assets | 99.19K | 335.69K | 1.25M | 0.00 |
| (Decrease) Increase In Payables | -120.35K | 658.41K | 255.35K | -439.85K |
| (Decrease) Increase In Other Current Liabilities | -145.48K | -1.09M | -296.58K | 77.37K |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 722.10K |
| Other Non-Cash Items | 5.63M | -1.53M | 8.92M | 4.60M |
| Net Cash From Continuing Operations | -214.25K | -955.22K | -5.08M | -5.25M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -214.25K | -955.22K | -5.08M | -5.25M |
| Sale of Property, Plant & Equipment | 395.43K | 394.01K | 376.38K | 1.55M |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 708.86K | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -859.63K | -1.13M | -809.95K | -1.06M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -539.96K | -11.46K |
| Other Cash from Investing Activities | 66.12K | -60.92K | 62.51K | 98.86K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 310.79K | -794.50K | -911.02K | 575.96K |
| Issuance of Debt | 2.41M | 272.18K | 795.32K | 2.04M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 2.51M | 982.44K | 11.92M | 3.75M |
| Repayment of Long-Term Debt | -3.66M | -1.30M | -10.99M | -4.37M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 522.39K | -382.35K | -857.83K | 0.00 |
| Net Cash From Financing Activities | 1.78M | -423.82K | 867.14K | 1.42M |
| Effect of Exchange Rate Changes | 958.82K | -1.02M | -490.76K | 47.28K |
| Net Change in Cash & Cash Equivalents | 2.83M | -3.20M | -5.61M | -3.21M |
Portfolios with EDAP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserWatch
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ProRobert Bruce
- UserSusu's Stocks
Latest EDAP Headlines from TheStreet
- EDAP Reports 23% Increase In First Quarter 2013 Revenues 05.16.13 | 07:05 am
- EDAP's Ablatherm-HIFU Receives Two Best Poster Awards At 2013 American Urological Association Annual Meeting 05.14.13 | 09:05 am
- EDAP Schedules Webcast And Conference Call For First Quarter 2013 Results 05.13.13 | 02:05 pm
- EDAP Outlines Significant Participation At 2013 American Urological Association Annual Meeting 05.01.13 | 09:05 am
- 5 Health Care Stocks Under $10 to Watch 04.30.13 | 02:04 pm
- EDAP Announces 23% First Quarter 2013 Revenue Growth 04.11.13 | 08:04 am
- EDAP Reports Fourth Quarter 2012 And Full Year Results 04.02.13 | 07:04 am
- EDAP Receives U.S. FDA Filing Acceptance Of Pre-Market Approval Application 03.28.13 | 08:03 am
- EDAP Introduces Focal.One(R): A New Robotic HIFU Device For Focal Therapy Of Prostate Cancer 03.14.13 | 08:03 am
- EDAP Schedules Webcast And Conference Call For Fourth Quarter And Full Year 2012 Results 03.12.13 | 08:03 am
Press Releases for EDAP
Partner Headlines for EDAP
- EDAP: An Undervalued Company With An Alternative Treatment For Prostate Cancer - Seeking Alpha 01.03.13 | 09:01 am
- EDAP TMS SA to Raise $5.625 Million in Registered Direct Offering - Benzinga 03.23.12 | 09:03 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- EDAP Receives South Korean FDA Approval for Sonolith i-move - Benzinga 12.13.10 | 09:12 am
- Movement in Medical Device Small Caps - Seeking Alpha 11.12.10 | 05:11 pm
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 04.19.10 | 09:04 am
- UPDATE 1-EDAP ultrasound device gets European nod; shares rise - Reuters 04.12.10 | 10:04 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 04.06.10 | 09:04 am
